Cabotegravir and Rilpivirine: A Long-Acting Injectable Antiretroviral Treatment for Human Immunodeficiency Virus
Author:
Funder
Substance Abuse and Mental Health Services Administration
Publisher
Elsevier BV
Subject
Advanced and Specialized Nursing
Reference32 articles.
1. Pneumocystis pneumonia–Los Angeles. 1981;MMWR Morb Mortal Wkly Rep,1996
2. Non-persistence to antiretroviral therapy among adults receiving HIV medical care in the United States;Nyaku;AIDS Care,2019
3. Advantages to using social-behavioral models of medication adherence in research and practice;Amico;J Gen Intern Med,2018
4. From access to engagement: measuring retention in outpatient HIV clinical care;Mugavero;AIDS Patient Care STDS,2010
5. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel;Thompson;Ann Intern Med,2012
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Human immunodeficiency virus infection challenges: Current therapeutic limitations and strategies for improved management through long‐acting injectable formulation;Reviews in Medical Virology;2024-06-17
2. Bictegravir nanomicelles and anionic pullulan loaded vaginal film: Dual mechanistic pre-exposure prophylaxis (PrEP) for HIV;International Journal of Biological Macromolecules;2022-11
3. Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV;Expert Review of Anti-infective Therapy;2022-06-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3